Norwegian Chapter in the Chambers Life Sciences & Pharma IP Litigation 2026
Vebjørn Iversen, Nora Bratheim, Kristine Rist Remseth and Guro S. Kyrkjebø Nybø have contributed to the Norwegian chapter in the Chambers and Partners Life Sciences & Pharma IP Litigation 2026 Global Practice Guide.
Lesetid 1 minutt
Our IP litigation specialists Nora Bratheim, Kristine Rist Remseth and Guro S. Kyrkjebø Nybø have contributed to the Norwegian chapter in the Chambers *Life Sciences & Pharma IP Litigation 2026* Global Practice Guide.
In this chapter, we provide legal analysis and practical insights on key issues in life sciences and pharmaceutical IP litigation in Norway – including patent disputes, generic and biosimilar market entry, SPCs/patent term extensions and available remedies. The content is particularly relevant for companies operating within pharmaceuticals, medical devices, health and biotechnology, as well as anyone working with IP litigation more generally.
Read more about our contribution and last year’s edition here, and access the latest guide and the Norway chapter via Chambers and Partners.
Life Sciences & Pharma IP Litigation 2026 - Norway | Global Practice Guides | Chambers and Partners